CUBT
Curative Biotechnology Inc
NYSE MKT: CUBT · HEALTHCARE · BIOTECHNOLOGY
$0.94
+0.00% today
Updated 2026-04-29
Market cap
$1.07B
P/E ratio
—
P/S ratio
158.53x
EPS (TTM)
$-0.72
Dividend yield
—
52W range
$0 – $1
Volume
0.1M
Curative Biotechnology Inc (CUBT) Financial statements
SEC filings — annual and quarterly data.
Income statement — annual
| Item | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $128392.00 | $159818.00 | $133995.00 | $323825.00 | $132324.00 | $113264.00 | $11091.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | — | — |
| Revenue growth (YoY) | — | +24.5% | -16.2% | +141.7% | -59.1% | -14.4% | -90.2% | -100.0% | — | — | — | — | — | — | — |
| Cost of revenue | $451320.00 | $153911.00 | $199933.00 | $15761.00 | $32113.00 | $27201.00 | $407.00 | $5301.00 | $5301.00 | $5301.00 | $5301.00 | $6744.00 | $7955.00 | $97515.00 | $92213.00 |
| Gross profit | $-323000.00 | $5906.00 | $-65938.00 | $308064.00 | $100211.00 | $86063.00 | $10684.00 | $-5301.00 | $-5301.00 | $-5301.00 | $-5301.00 | $-6744.00 | $-7955.00 | $-97515.00 | $-92213.00 |
| Gross margin | -251.6% | 3.7% | -49.2% | 95.1% | 75.7% | 76.0% | 96.3% | — | — | — | — | — | — | — | — |
| R&D | — | — | — | — | — | — | — | — | — | — | $0.00 | $779275.00 | $2.48M | $269782.00 | $14027.00 |
| SG&A | — | — | — | $57860.00 | $36828.00 | — | $6884.00 | $1800.00 | $150.00 | $150.00 | $4.60M | $4.21M | $1.95M | $1.56M | $2.25M |
| Operating income | $-1.01M | $-463000.00 | $-285000.00 | $-39206.00 | $-57045.00 | $-87150.00 | $-1518.00 | $-7101.00 | $-5451.00 | $-5451.00 | $-4.64M | $-5.01M | $-4.47M | $-1.93M | $-2.44M |
| Operating margin | -786.7% | -289.7% | -212.7% | -12.1% | -43.1% | -76.9% | -13.7% | — | — | — | — | — | — | — | — |
| EBITDA | $-855000.00 | $-447000.00 | $-269000.00 | $-31742.00 | $-70756.00 | $217962.00 | $3800.00 | $-1800.00 | $-8731.00 | $-150.00 | $-4.60M | $-5.16M | $-4.36M | $-2.50M | $-2.35M |
| EBITDA margin | -665.9% | -279.7% | -200.8% | -9.8% | -53.5% | 192.4% | 34.3% | — | — | — | — | — | — | — | — |
| EBIT | $-871802.00 | $-462456.00 | $-284314.00 | $-41613.00 | $-82000.00 | $206718.00 | $-1518.00 | $-7101.00 | $-14032.00 | $-5451.00 | $-4.60M | $-5.16M | $-4.46M | $-2.60M | $-2.44M |
| Interest expense | $41909.00 | $28853.00 | $21521.00 | $0.00 | $0.00 | $15882.00 | $15882.00 | $15882.00 | $15882.00 | $15882.00 | $34516.00 | $176672.00 | $918487.00 | $1.36M | $1.13M |
| Income tax | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Effective tax rate | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Net income | $-913000.00 | $-492000.00 | $-306000.00 | $-63138.00 | $-77919.00 | $190836.00 | $-17400.00 | $-22983.00 | $-29914.00 | $331953.00 | $-4.67M | $-5.34M | $-5.38M | $-3.96M | $-3.56M |
| Net income growth (YoY) | — | +46.1% | +37.8% | +79.4% | -23.4% | +344.9% | -109.1% | -32.1% | -30.2% | +1209.7% | -1506.8% | -14.3% | -0.7% | +26.4% | +9.9% |
| Profit margin | -711.1% | -307.9% | -228.4% | -19.5% | -58.9% | 168.5% | -156.9% | — | — | — | — | — | — | — | — |